chrysamine g has been researched along with Huntington Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boeddrich, A; Heiser, V; Lehrach, H; Lurz, R; Nordhoff, E; Scherzinger, E; Schugardt, N; Wanker, EE | 1 |
Bates, GP; Hockly, E; Klunk, WE; Li, XJ; Mahal, A; Murray, KD; Portier, R; Smith, DL; Wanker, E; Woodman, B | 1 |
2 other study(ies) available for chrysamine g and Huntington Disease
Article | Year |
---|---|
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.
Topics: Animals; Antibodies, Monoclonal; Benzoates; Benzothiazoles; Biphenyl Compounds; Congo Red; COS Cells; Gossypol; Humans; Huntingtin Protein; Huntington Disease; Melatonin; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Rifampin; Thiazoles | 2000 |
Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.
Topics: Animals; Benzoates; Biphenyl Compounds; Cells, Cultured; Coloring Agents; Congo Red; Creatine; Cysteine Endopeptidases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Energy Metabolism; Female; Hippocampus; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nuclear Proteins; Organ Culture Techniques; Peptides; Proteasome Endopeptidase Complex; Protein Folding; Trinucleotide Repeat Expansion; Ubiquitin | 2001 |